Shareholding disclosure
Newron Pharmaceuticals S.p.A.
Collectively declared rate
22.03%
Threshold
Crossed upwards
Timeline
Published
05.11.2015
Transaction
02.11.2015
Voting rights breakdown
Declared beneficial owners · 2
A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.
Notice details
Notification ID
TBFB300057
Beneficial owner
Investor AB
Declared address
Investor AB, 10332 Stockholm
Change to the composition of the group by an indirect sale resulting from an intra-group transfer within the Investor group of the shares in Duba from Investor to Patricia Industries II. For clarification,Investor remains the beneficial owner. As of the date of this notice, the Newron shares are held dIrectly by Zambon and Duba Zambon Company S.p.A. Via Lillo del Duca n. 10,20091 - Bresso (Milan), Italy, Registry of Companies of Milan n. 01690280159 ("Zambon") is an entily controlled at 85.92% by GEFIM. Duba AB, Arsenalsgatan No. 8 C, 103 32, Stockholm, Sweden, registered number 556593-5508 ( Duba ) is (as of the date of this notice, a wholly-owned direct subsidiary of Patricia Industries II AB, 103 32 Stockholm, Sweden, registered number 556619-6811 ( Patricia Industries II ). Patricia Industries II is a wholly-owned direct subsidiary of Investor. On 21 January 2013, Zambon and Duba entered into a shareholders agreement relating to their respective stakes in Newron.
insider24.ch
Never miss a market signal again
Need more? Discover the Pro plan